Story perspectives

Women's Health Ventures: Underfunded Despite Rising Demand

9/9/2025

48 10

Summary

Story summary

From 2019 to 2023, erectile dysfunction startups secured 28 times more funding than endometriosis ventures, despite endometriosis affecting 1 in 10 women.
Heart disease, the leading cause of death in women, often leads to misdiagnosis due to atypical symptoms.
Women represent 75% of autoimmune disease patients, yet they face longer diagnosis times than men.
Investment in women's health is recognized as a viable market with significant profit potential.
In 2023, women's health received under 2% of healthcare venture capital, despite rising demand.

1 of 1

Story summary

From 2019 to 2023, erectile dysfunction startups secured 28 times more funding than endometriosis ventures, despite endometriosis affecting 1 in 10 women.
Heart disease, the leading cause of death in women, often leads to misdiagnosis due to atypical symptoms.
Women represent 75% of autoimmune disease patients, yet they face longer diagnosis times than men.
Investment in women's health is recognized as a viable market with significant profit potential.
In 2023, women's health received under 2% of healthcare venture capital, despite rising demand.